Satyam, Sciformix to help drug cos with data management

RELATED NEWS Satyam’s Leadership Certification Process wins ASTD Award Satyam awarded Tier 1 Engineering Supplier Status by EADS Satyam positioned in Challengers Quadrant for BI, PM Srvs Satyam earns Top Awards at Computerworld Honors Program ALSO READ See latest News about Mahindra Satyam See previous management interviews See what other Experts & Brokerages are saying about Mahindra Satyam Mahindra Satyam BSE | NSE 28/05/12 Are Mutual Funds betting on Mahindra Satyam?

 

The partnership addresses the worldwide increase in focus on drug safety, which is leading to a growing number of adverse events being reported to the regulatory authorities.

The alliance also enables organisations to offer these services in a way that is both cost-efficient and scalable via a proven global delivery model. Sciformix has an in-depth understanding of the pharmaceutical and life sciences domain, while Satyam has proven drug safety business process outsourcing capabilities.

According to Mr Kishore Rachapudi, Satyam's global head of life sciences, "We will leverage our extensive experience managing large-scale IT and BPO solutions and work with Sciformix to offer a scalable platform for delivery of drug safety services."

Several high-profile withdrawals of popular drugs from the marketplace have also made this partnership more important. The withdrawals have pharmaceutical companies looking for ways to manage risk and take a more proactive approach toward collection and assessment of drug safety information.

Taken from Business Line

thehindubusinessline.in